(19)
(11) EP 1 390 385 A2

(12)

(88) Date of publication A3:
20.02.2003

(43) Date of publication:
25.02.2004 Bulletin 2004/09

(21) Application number: 02752028.7

(22) Date of filing: 29.05.2002
(51) International Patent Classification (IPC)7: C07H 21/04, C12Q 1/68, C12N 5/00
(86) International application number:
PCT/US2002/017674
(87) International publication number:
WO 2002/096927 (05.12.2002 Gazette 2002/49)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.05.2001 US 870161
30.11.2001 US 334461 P
03.05.2002 US 138674

(71) Applicants:
  • Sirna Therapeutics, Inc.
    Boulder, CO 80301 (US)
  • CHIRON CORPORATION
    EmeryvilleCalifornia 94608-2916 (US)

(72) Inventors:
  • ESCOBEDO, Jaime
    Alamo, CA 94507 (US)
  • MCSWIGGEN, James
    Boulder, CO 80301 (US)
  • PAVCO, Pamela
    Lafayette, CO 80026 (US)
  • STINCHCOMB, Dan
    Ft. Collins, CO 80528 (US)
  • SANDBERG, Jennifer
    Longmont, CO 80503 (US)
  • GORDON, Gilad
    Boulder, CO 80305 (US)

(74) Representative: Maschio, Antonio, Dr. et al
D Young & Co,21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) NUCLEIC ACID BASED MODULATION OF FEMALE REPRODUCTIVE DISEASES AND CONDITIONS